Annual EBIT
-$684.30 M
-$1.52 B-182.14%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual earnings before interest & taxes is -$684.30 million, with the most recent change of -$1.52 billion (-182.14%) on December 31, 2023.
- During the last 3 years, VIR annual EBIT has fallen by -$387.32 million (-130.42%).
- VIR annual EBIT is now -182.14% below its all-time high of $833.07 million, reached on December 31, 2022.
Performance
VIR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$218.59 M
-$86.24 M-65.16%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly earnings before interest & taxes is -$218.59 million, with the most recent change of -$86.24 million (-65.16%) on September 30, 2024.
- Over the past year, VIR quarterly EBIT has dropped by -$86.24 million (-65.16%).
- VIR quarterly EBIT is now -121.56% below its all-time high of $1.01 billion, reached on March 31, 2022.
Performance
VIR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$578.78 M
-$35.23 M-6.48%
September 30, 2024
Summary
- As of February 7, 2025, VIR TTM earnings before interest & taxes is -$578.78 million, with the most recent change of -$35.23 million (-6.48%) on September 30, 2024.
- Over the past year, VIR TTM EBIT has dropped by -$35.23 million (-6.48%).
- VIR TTM EBIT is now -136.33% below its all-time high of $1.59 billion, reached on March 31, 2022.
Performance
VIR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VIR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -182.1% | -65.2% | -6.5% |
| 3 y3 years | -130.4% | -52.5% | -78.6% |
| 5 y5 years | -476.5% | -52.5% | -78.6% |
VIR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -182.1% | at low | -121.6% | +2.9% | -136.3% | +15.8% |
| 5 y | 5-year | -182.1% | at low | -121.6% | +2.9% | -136.3% | +15.8% |
| alltime | all time | -182.1% | at low | -121.6% | +2.9% | -136.3% | +15.8% |
Vir Biotechnology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$218.59 M(+65.2%) | -$578.78 M(+6.5%) |
| Jun 2024 | - | -$132.35 M(+65.3%) | -$543.55 M(-12.5%) |
| Mar 2024 | - | -$80.08 M(-45.8%) | -$621.01 M(-9.2%) |
| Dec 2023 | -$684.30 M(-182.1%) | -$147.75 M(-19.4%) | -$684.30 M(-0.4%) |
| Sep 2023 | - | -$183.36 M(-12.6%) | -$687.05 M(+122.5%) |
| Jun 2023 | - | -$209.82 M(+46.3%) | -$308.73 M(-4.8%) |
| Mar 2023 | - | -$143.37 M(-4.7%) | -$324.13 M(-138.9%) |
| Dec 2022 | $833.07 M(+98.0%) | -$150.50 M(-177.2%) | $833.07 M(-46.4%) |
| Sep 2022 | - | $194.96 M(-186.6%) | $1.56 B(+19.0%) |
| Jun 2022 | - | -$225.22 M(-122.2%) | $1.31 B(-18.0%) |
| Mar 2022 | - | $1.01 B(+77.3%) | $1.59 B(+278.7%) |
| Dec 2021 | $420.75 M | $571.75 M(-1171.0%) | $420.75 M(-262.2%) |
| Sep 2021 | - | -$53.38 M(-187.5%) | -$259.40 M(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $61.02 M(-138.5%) | -$293.63 M(-23.5%) |
| Mar 2021 | - | -$158.63 M(+46.3%) | -$383.70 M(+29.2%) |
| Dec 2020 | -$296.98 M(+66.9%) | -$108.40 M(+23.7%) | -$296.98 M(+17.7%) |
| Sep 2020 | - | -$87.61 M(+201.6%) | -$252.34 M(+18.8%) |
| Jun 2020 | - | -$29.05 M(-59.6%) | -$212.40 M(-3.1%) |
| Mar 2020 | - | -$71.91 M(+12.8%) | -$219.12 M(+23.1%) |
| Dec 2019 | -$177.98 M(+50.0%) | -$63.76 M(+33.7%) | -$177.98 M(+26.2%) |
| Sep 2019 | - | -$47.68 M(+33.3%) | -$141.01 M(+10.4%) |
| Jun 2019 | - | -$35.77 M(+16.2%) | -$127.68 M(+38.9%) |
| Mar 2019 | - | -$30.77 M(+14.8%) | -$91.91 M(+50.3%) |
| Dec 2018 | -$118.69 M(+45.6%) | -$26.80 M(-22.0%) | -$61.14 M(+78.0%) |
| Sep 2018 | - | -$34.35 M | -$34.35 M |
| Dec 2017 | -$81.50 M | - | - |
FAQ
- What is Vir Biotechnology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vir Biotechnology?
- What is Vir Biotechnology annual EBIT year-on-year change?
- What is Vir Biotechnology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vir Biotechnology?
- What is Vir Biotechnology quarterly EBIT year-on-year change?
- What is Vir Biotechnology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vir Biotechnology?
- What is Vir Biotechnology TTM EBIT year-on-year change?
What is Vir Biotechnology annual earnings before interest & taxes?
The current annual EBIT of VIR is -$684.30 M
What is the all time high annual EBIT for Vir Biotechnology?
Vir Biotechnology all-time high annual earnings before interest & taxes is $833.07 M
What is Vir Biotechnology annual EBIT year-on-year change?
Over the past year, VIR annual earnings before interest & taxes has changed by -$1.52 B (-182.14%)
What is Vir Biotechnology quarterly earnings before interest & taxes?
The current quarterly EBIT of VIR is -$218.59 M
What is the all time high quarterly EBIT for Vir Biotechnology?
Vir Biotechnology all-time high quarterly earnings before interest & taxes is $1.01 B
What is Vir Biotechnology quarterly EBIT year-on-year change?
Over the past year, VIR quarterly earnings before interest & taxes has changed by -$86.24 M (-65.16%)
What is Vir Biotechnology TTM earnings before interest & taxes?
The current TTM EBIT of VIR is -$578.78 M
What is the all time high TTM EBIT for Vir Biotechnology?
Vir Biotechnology all-time high TTM earnings before interest & taxes is $1.59 B
What is Vir Biotechnology TTM EBIT year-on-year change?
Over the past year, VIR TTM earnings before interest & taxes has changed by -$35.23 M (-6.48%)